Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-04

Clinical Trial Update: Effect of Metformin in Reducing Fatigue in Long COVID in Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether metformin reduces fatigue in adolescents with Long COVID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Purpose Life Sciences | Conditions: Long COVID | Phase 3 | Status: UNKNOWN